Therapeutic Asset Ratings

126 results matching 1 filter

129,767 assets · 8,707 sponsors · 3,128 indications

Methodology v0.2

Asset	Sponsor	Phase	Rating
Elebsiran Cirrhosis Of Liver	Vir Biotechnology, Inc.	P1	C (39)
Ncp-Cd47 Sirna Intratumorally Head And Neck Cancer	West China Hospital	P1	C (39)
Ncp-Cd47 Sirna Intratumorally Solid Tumor Cancer	West China Hospital	P1	C (39)
bmd003 Gene Therapy	Peking Union Medical College Hospital	Early P1	C (39)
Cd-Ga-102 Colorectal Cancer	Shanghai Changzheng Hospital	Early P1	C (39)
hnf4α srrna Colorectal Cancer	Shanghai Changzheng Hospital	Early P1	C (39)
bp1001-a Endometrial Carcinoma	Bio-Path Holdings, Inc.	P1	C (37)
bp1001-a Solid Tumor, Adult	Bio-Path Holdings, Inc.	P1	C (37)
Cpg-Odn Hepatocellular Carcinoma	Second Affiliated Hospital of Guangzhou Medical University	P1	C (37)
Cpg-Odn Lung Cancer	Second Affiliated Hospital of Guangzhou Medical University	P1	C (37)
bp1001-a Neoplasm	Bio-Path Holdings, Inc.	P1	C (36)
Cpg-Odn Neoplasm	Second Affiliated Hospital of Guangzhou Medical University	P1	C (36)
DNA, D(P-THIO)(T-G-A-C-T-G-T-G-A-A-C-G-T-T-C-G-A-G-A-T-G-A) UNCOSASODIUM Ovarian Cancer	PhotonPharma, Inc.	P1	C (36)
bmd003 Cystic Fibrosis	Peking Union Medical College Hospital	Early P1	C (36)
Cd-Ga-102 Metastatic Malignant Neoplasm In The Colon	Shanghai Changzheng Hospital	Early P1	C (34)
Nelitolimod Metastatic Malignant Neoplasm In The Colon	Northwell Health	Early P1	C (34)
Sepofarsen Blindness (Disorder)	Laboratoires Thea	P3	NR (0)
Sepofarsen Eye Disorder	Laboratoires Thea	P3	NR (0)
Sepofarsen Eye Diseases, Hereditary	Laboratoires Thea	P3	NR (0)
Sepofarsen Leber Congenital Amaurosis	Laboratoires Thea	P3	NR (0)
Sepofarsen Leber Congenital Amaurosis 10	Laboratoires Thea	P3	NR (0)
Sepofarsen Perceptual Disorders	Laboratoires Thea	P3	NR (0)
Sepofarsen Vision Disorder	Laboratoires Thea	P3	NR (0)
Opemalirsen Kidney Failure	AstraZeneca	P1	NR (0)
Mrna-Lnp Cancer	IntraAb, Inc.	P1/2	NR (0)

Showing 101 to 125 of 126 assets

PreviousPage 5 of 6Next